Following initial findings suggesting altered insulin sensitivity in migraine patients, several studies have explored the relationship between insulin resistance (IR), metabolic syndrome (MetS), and migraine, including the potential for targeted therapeutic interventions. This evidence concerns the gene INS and metabolic syndrome.